Is HIV index testing and partner notification safe for adolescent girls and young women in low- and middle-income countries?


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
09 2020
Historique:
received: 13 03 2020
revised: 22 05 2020
accepted: 05 06 2020
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 17 4 2021
Statut: ppublish

Résumé

While HIV index testing and partner notification (PN) services have the potential to reach adolescent girls and young women (AGYW) aged 15 to 24 and their sexual partners in need of HIV testing services, the potential social harms have not yet been studied. This commentary highlights the risks of this approach, including intimate partner violence (IPV), stigma and discrimination, and outlines an urgent research agenda to fully understand the potential harms of PN for AGYW, calling for the development of mitigation strategies. A substantial evidence base exists demonstrating the feasibility, acceptability and effectiveness of index testing and partner notification for adults aged 18 years and older in low- and middle-income countries (LMICs), particularly for men, and for adults who are married/cohabiting and referring a current sexual partner. AGYW who are most vulnerable to HIV infection in LMICs do not reflect these demographics. Instead, they are often in age-disparate partnerships, have limited negotiating power within relationships, experience high rates of violence and face economic challenges that necessitate transactional sex. PN services may be particularly difficult for adolescent girls under 18 who face restrictions on their decision making and are at increased risk of rape. Adolescent girls may also face coercion to notify partners due to unequal power dynamics in the provider-adolescent client relationship, as well as judgemental attitudes towards adolescent sexual activity among providers. As index testing and PN with AGYW is already being rolled out in some LMICs, research is urgently needed to assess its feasibility and acceptability. Implementation science studies should assess the availability, accessibility, acceptability and quality of HIV PN services for AGYW. Qualitative studies and routine monitoring with age-disaggregated data are critical to capture potential social harms, PN preferences and support needs for AGYW aged 15 to 17, 18 to 20 and 21 to 24. To mitigate potential harms, PN methods should prioritize confidentiality and avoidance of adverse outcomes. Healthcare providers should be trained to conduct routine enquiry for IPV and provide first-line support. Support services for AGYW living with HIV and survivors of violence should be implemented alongside HIV PN.

Identifiants

pubmed: 32869478
doi: 10.1002/jia2.25562
pmc: PMC7459168
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25562

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

© 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

Acad Emerg Med. 2015 Jan;22(1):61-6
pubmed: 25545855
Arch Pediatr Adolesc Med. 2002 Nov;156(11):1133-7
pubmed: 12413343
J Adolesc Health. 2009 Apr;44(4):356-62
pubmed: 19306794
J Int AIDS Soc. 2017 Aug 11;20(1):21456
pubmed: 28799324
Sex Transm Dis. 2011 Sep;38(9):821-7
pubmed: 21844737
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):46-52
pubmed: 29023252
World Health Organ Tech Rep Ser. 2006;938:151-204; discussion 317-41
pubmed: 16921920
BMC Public Health. 2015 May 02;15:455
pubmed: 25934557
Reprod Health. 2014 Dec 13;11:88
pubmed: 25495605
Soc Sci Med. 2001 Nov;53(10):1287-301
pubmed: 11676401
J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):276-82
pubmed: 11115959
J Int AIDS Soc. 2015 Mar 24;18:19462
pubmed: 25808633
J Public Health (Oxf). 2017 Jun 1;39(2):407-414
pubmed: 27222237
Int J Pediatr Adolesc Med. 2018 Mar;5(1):5-12
pubmed: 30805525
Lancet. 2004 May 1;363(9419):1415-21
pubmed: 15121402
AIDS Behav. 2017 Aug;21(8):2551-2560
pubmed: 28299518
AIDS Behav. 2018 Jan;22(1):102-116
pubmed: 29090397
Front Public Health. 2018 Jun 21;6:165
pubmed: 29977887
J Int AIDS Soc. 2017 Dec;20(4):
pubmed: 29219248
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):296-304
pubmed: 30113403
Am J Community Psychol. 2013 Mar;51(1-2):176-89
pubmed: 22718087
AIDS. 2017 Jul 01;31 Suppl 3:S195-S201
pubmed: 28665877
Sex Transm Dis. 2003 Jan;30(1):75-82
pubmed: 12514447
J Int AIDS Soc. 2018 Feb;21 Suppl 1:
pubmed: 29485749
PLoS One. 2018 Apr 2;13(4):e0195163
pubmed: 29608595
BMC Public Health. 2018 Aug 6;18(1):980
pubmed: 30081960
AIDS. 2017 Aug 24;31(13):1867-1876
pubmed: 28590326
Curr HIV/AIDS Rep. 2015 Jun;12(2):207-15
pubmed: 25855338
J Adolesc Health. 2019 Apr;64(4):427-429
pubmed: 30904091
Prog Community Health Partnersh. 2007 Fall;1(3):221-9
pubmed: 20208284
Bull World Health Organ. 2019 Jan 1;97(1):42-50
pubmed: 30618464
Sex Transm Dis. 1999 Sep;26(8):483-9
pubmed: 10494941
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947
Can J Public Health. 2012 Jan-Feb;103(1):14-8
pubmed: 22338322
Lancet. 2010 Jul 3;376(9734):41-8
pubmed: 20557928
Sex Transm Infect. 2018 Mar;94(2):144-150
pubmed: 29191815
Malawi Med J. 2015 Dec;27(4):140-4
pubmed: 26955435
Lancet HIV. 2017 Feb;4(2):e74-e82
pubmed: 27913227
Lancet HIV. 2015 Nov;2(11):e483-91
pubmed: 26520928
J Int AIDS Soc. 2014 Mar 10;17:18866
pubmed: 24629845

Auteurs

Anne L Stangl (AL)

International Center for Research on Women, Washington, DC, USA.
Hera Solutions, Baltimore, MD, USA.

Meroji Sebany (M)

International Center for Research on Women, Washington, DC, USA.

Chisina Kapungu (C)

International Center for Research on Women, Washington, DC, USA.

Cassandra Jessee (C)

International Center for Research on Women, Washington, DC, USA.
Making Cents International, Washington, DC, USA.

Chelsea L Ricker (CL)

International Center for Research on Women, Washington, DC, USA.
Independent Consultant, Washington, DC, USA.

Eliza Chard (E)

Making Cents International, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH